Combination of Cetuximab and Oncolytic Virus Canerpaturev Synergistically Inhibits Human Colorectal Cancer Growth

Title
Combination of Cetuximab and Oncolytic Virus Canerpaturev Synergistically Inhibits Human Colorectal Cancer Growth
Authors
Keywords
HSV, cetuximab, oncolytic herpes virus HF10, C-REV, human colorectal cancer
Journal
Molecular Therapy-Oncolytics
Volume 13, Issue -, Pages 107-115
Publisher
Elsevier BV
Online
2019-05-14
DOI
10.1016/j.omto.2019.04.004

Ask authors/readers for more resources

Reprint

Contact the author

Find Funding. Review Successful Grants.

Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.

Explore

Ask a Question. Answer a Question.

Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.

Get Started